Principal: A prospective observational study of real-world treatment patterns and treatment outcomes in patients with advanced or metastatic renal cell carcinoma (mRCC) receiving pazopanib.
Aristotelis Bamias
Consultant or Advisory Role - Bayer; Pfizer; Roche
Honoraria - Bayer; GlaxoSmithKline; Janssen; Novartis; Roche
Research Funding - Roche
Petri Bono
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer
Research Funding - GlaxoSmithKline; Pfizer
Giuseppe Procopio
Consultant or Advisory Role - AVEO; Bayer; GlaxoSmithKline
Honoraria - AVEO; Bayer; GlaxoSmithKline; Pfizer
Edwin Herrmann
No relevant relationships to disclose
Sergio Vazquez-Estevez
No relevant relationships to disclose
Angel Rodriguez Sanchez
No relevant relationships to disclose
Narayanan Srihari
Research Funding - GlaxoSmithKline
Dirk L. Schrijvers
Consultant or Advisory Role - Johnson & Johnson
Honoraria - Janssen
Research Funding - Janssen
Robert E. Hawkins
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Expert Testimony - GlaxoSmithKline
Other Remuneration - GlaxoSmithKline
Nicholas J. Vogelzang
Employment or Leadership Position - US Oncology
Consultant or Advisory Role - Celgene
Honoraria - Roche
Other Remuneration - Dendreon
Francisco J. Sapunar
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Dipak Kothari
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Sadya Khan
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Faisal Mehmud
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Eric Jonasch
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer
Research Funding - GlaxoSmithKline; Novartis; Onyx; Pfizer
Manuela Schmidinger
Consultant or Advisory Role - Astellas Pharma; GlaxoSmithKline; Novartis; Pfizer; Roche
Honoraria - Astellas Pharma; GlaxoSmithKline; Novartis; Pfizer; Roche
Research Funding - GlaxoSmithKline; Pfizer; Roche
Expert Testimony - Pfizer